Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
Clinical trial NCT07047586 · RECRUITING
Trial details
- NCT number
- NCT07047586
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2028-06-30
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.